Combination effect of PectaSol and Doxorubicin on viability, cell cycle arrest and apoptosis in DU‐145 and LNCaP prostate cancer cell lines
Authors:
- 1 July 2012
- journal article
- Published by Wiley in Cell Biology International
- Vol. 36 (7) , 601-610
Abstract
The effect of PectaSol on Dox (Doxorubicin) cytotoxicity in terms of apoptosis and cell cycle changes in PCa (prostate cancer) cell lines (DU‐145 and LNCaP) has been investigated. Combination of PectaSol and Dox resulted in a viability of 29.4 and 32.6% (P50 values decreased 1.5‐fold and 1.3‐fold in the DU‐145 and LNCaP cells respectively. In the DU‐145 cells, combination of PectaSol and Dox resulted in a reduction in p27 gene and protein expression (P1 arrest (54.6% compared with 12.2% in Dox). In LNCaP cells, combination of the drugs led to an increased in G2/M arrest (61.7% compared with 53.6% in Dox). Based on these findings, progressive cytotoxicity effect of Dox and PectaSol together rapidly induce cell death in DU‐145 through apoptosis and in LNCaP cells through cell cycle arrest (G2/M arrest).Keywords
This publication has 19 references indexed in Scilit:
- In vivo evaluation of a novel albumin-binding prodrug of doxorubicin in an orthotopic mouse model of prostate cancer (LNCaP)Prostate Cancer and Prostatic Diseases, 2010
- Modified citrus pectin anti-metastatic properties: one bullet, multiple targetsCarbohydrate Research, 2009
- siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cellsMolecular Cancer, 2009
- Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cellsAnti-Cancer Drugs, 2007
- Galectin-3 as a Potential Therapeutic Target in Tumors Arising from Malignant EndotheliaNeoplasia, 2007
- Pectin induces apoptosis in human prostate cancer cells: correlation of apoptotic function with pectin structureGlycobiology, 2007
- Phellinus linteus sensitises apoptosis induced by doxorubicin in prostate cancerBritish Journal of Cancer, 2006
- Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaPProstate Cancer and Prostatic Diseases, 2005
- Loss of MYC Confers Resistance to Doxorubicin-induced Apoptosis by Preventing the Activation of Multiple Serine Protease- and Caspase-mediated PathwaysJournal of Biological Chemistry, 2004
- Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot studyProstate Cancer and Prostatic Diseases, 2003